GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...
The results were concerning. People who used at least one of these drugs had a 47% higher risk of developing mild cognitive impairment, or MCI, over the next decade. MCI is an early stage of memory ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
A major new study has cast doubt on the claim that the cholesterol-lowering drugs might cause memory problems or other ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results